KPMA and KMA to agree over rebate issues.

The pharmaceutical industry and the medical community have agreed to eliminate protracted irregularities related with drug supply deals between hospitals and drug industries, viewing it as the way for them to get people's credibility only when the drug supplies being dealt in transparency.

They also shared with a common view that a part of rebate practice had been abused in giving negative i...